Published in Proc Natl Acad Sci U S A on October 25, 2007
Endoplasmic reticulum stress in disorders of myelinating cells. Nat Neurosci (2009) 1.76
XBP-1-deficient plasmablasts show normal protein folding but altered glycosylation and lipid synthesis. J Immunol (2009) 1.02
The multiple roles of myelin protein genes during the development of the oligodendrocyte. ASN Neuro (2010) 0.97
Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes. Front Genet (2012) 0.94
Myelin under stress. J Neurosci Res (2009) 0.94
Pelizaeus-Merzbacher-like disease is caused not only by a loss of connexin47 function but also by a hemichannel dysfunction. Eur J Hum Genet (2010) 0.90
Axon-glia interaction and membrane traffic in myelin formation. Front Cell Neurosci (2014) 0.90
Differences in endoplasmic-reticulum quality control determine the cellular response to disease-associated mutants of proteolipid protein. J Cell Sci (2009) 0.89
Autophagy promotes oligodendrocyte survival and function following dysmyelination in a long-lived myelin mutant. J Neurosci (2013) 0.88
Spatial Intensity Distribution Analysis Reveals Abnormal Oligomerization of Proteins in Single Cells. Biophys J (2015) 0.88
Mutation of sec63 in zebrafish causes defects in myelinated axons and liver pathology. Dis Model Mech (2012) 0.86
Different proteolipid protein mutants exhibit unique metabolic defects. ASN Neuro (2009) 0.83
Insertion of proteolipid protein into oligodendrocyte mitochondria regulates extracellular pH and adenosine triphosphate. Glia (2013) 0.82
Interaction of PLP with GFP-MAL2 in the human oligodendroglial cell line HOG. PLoS One (2011) 0.81
Microwave and magnetic (M(2) ) proteomics of the experimental autoimmune encephalomyelitis animal model of multiple sclerosis. Electrophoresis (2012) 0.81
The safety dance: biophysics of membrane protein folding and misfolding in a cellular context. Q Rev Biophys (2014) 0.80
Elevated CSF N-acetylaspartylglutamate suggests specific molecular diagnostic abnormalities in patients with white matter diseases. Biochim Biophys Acta (2010) 0.79
Cellular response to micropatterned growth promoting and inhibitory substrates. BMC Biotechnol (2013) 0.77
A role for the membrane protein M6 in the Drosophila visual system. BMC Neurosci (2012) 0.76
Endoplasmic Reticulum Protein Quality Control Failure in Myelin Disorders. Front Mol Neurosci (2017) 0.75
Cellular Pathology of Pelizaeus-Merzbacher Disease Involving Chaperones Associated with Endoplasmic Reticulum Stress. Front Mol Biosci (2017) 0.75
Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules. NPJ Schizophr (2015) 0.75
Novel molecular insights into the critical role of sulfatide in myelin maintenance/function. J Neurochem (2016) 0.75
Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes. Am J Hum Genet (2017) 0.75
Concise Review: Stem Cell-Based Treatment of Pelizaeus-Merzbacher Disease. Stem Cells (2016) 0.75
Fluorescent flavonoids for endoplasmic reticulum cell imaging. J Mater Chem B Mater Biol Med (2016) 0.75
XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell (2001) 18.68
Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol (2003) 9.85
Protein oligomerization in the endoplasmic reticulum. Annu Rev Cell Biol (1989) 8.22
A trip to the ER: coping with stress. Trends Cell Biol (2004) 7.67
Transcriptional and translational control in the Mammalian unfolded protein response. Annu Rev Cell Dev Biol (2002) 6.48
Setting the standards: quality control in the secretory pathway. Science (1999) 6.41
Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. Curr Opin Cell Biol (2001) 5.08
Developmental regulation of IgM secretion: the role of the carboxy-terminal cysteine. Cell (1990) 2.12
Assembly of CNS myelin in the absence of proteolipid protein. Neuron (1997) 1.93
The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron (2002) 1.91
Lines of murine oligodendroglial precursor cells immortalized by an activated neu tyrosine kinase show distinct degrees of interaction with axons in vitro and in vivo. Eur J Neurosci (1995) 1.83
Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood (2006) 1.61
Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J Cell Biol (1998) 1.53
Quality control of ER synthesized proteins: an exposed thiol group as a three-way switch mediating assembly, retention and degradation. EMBO J (1993) 1.44
A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nat Genet (1996) 1.39
Molecular genetics of X-linked Charcot-Marie-Tooth disease. Neuromolecular Med (2006) 1.31
Proteolipid protein (PLP) of CNS myelin: positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP. Biochemistry (1992) 1.31
The dynamic ER: experimental approaches and current questions. Curr Opin Cell Biol (2005) 1.30
Major Myelin proteolipid: the 4-alpha-helix topology. J Membr Biol (1991) 1.23
Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): evidence that PLP misfolding underlies dysmyelination in mutant mice. J Neurosci (1996) 1.20
Role of calnexin in the glycan-independent quality control of proteolipid protein. EMBO J (2003) 1.19
Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc Natl Acad Sci U S A (1994) 1.18
Misfolding of collagen X chains harboring Schmid metaphyseal chondrodysplasia mutations results in aberrant disulfide bond formation, intracellular retention, and activation of the unfolded protein response. J Biol Chem (2005) 1.10
Disease-associated mutations cause premature oligomerization of myelin proteolipid protein in the endoplasmic reticulum. Proc Natl Acad Sci U S A (2005) 0.88
Novel alternatively spliced endoplasmic reticulum retention signal in the cytoplasmic loop of Proteolipid Protein-1. J Neurosci Res (2007) 0.83
Pelizaeus-Merzbacher disease: three novel mutations and implication for locus heterogeneity. Ann Neurol (1999) 0.82
Topology of proteolipid protein in the myelin membrane of central nervous system. A study using antipeptide antibodies. Biol Chem Hoppe Seyler (1989) 0.80
Orientation of myelin proteolipid protein in the oligodendrocyte cell membrane. Neurochem Res (1996) 0.80
Axonal neuregulin-1 regulates myelin sheath thickness. Science (2004) 6.09
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet (2003) 5.43
Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci (2008) 5.15
The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron (2006) 4.12
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature (2012) 3.09
Axonal transport defects in neurodegenerative diseases. J Neurosci (2009) 2.74
Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol (2013) 2.61
Genetic targeting of principal neurons in neocortex and hippocampus of NEX-Cre mice. Genesis (2006) 2.52
Neurod1 is essential for the survival and maturation of adult-born neurons. Nat Neurosci (2009) 2.38
High cholesterol level is essential for myelin membrane growth. Nat Neurosci (2005) 2.34
Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet (2007) 2.30
Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. J Neurosci (2005) 2.27
Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci (2010) 2.25
Monitoring regulated protein-protein interactions using split TEV. Nat Methods (2006) 2.24
Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med (2003) 2.17
Bcl-x L increases mitochondrial fission, fusion, and biomass in neurons. J Cell Biol (2009) 1.97
Elevated phosphatidylinositol 3,4,5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination. J Neurosci (2010) 1.93
Pancreatic beta cells require NeuroD to achieve and maintain functional maturity. Cell Metab (2010) 1.88
Pyramidal neurons of upper cortical layers generated by NEX-positive progenitor cells in the subventricular zone. Proc Natl Acad Sci U S A (2005) 1.77
Essential and distinct roles for cdc42 and rac1 in the regulation of Schwann cell biology during peripheral nervous system development. J Cell Biol (2007) 1.69
Notch1 control of oligodendrocyte differentiation in the spinal cord. J Cell Biol (2002) 1.65
Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science (2011) 1.64
Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: Trophic support for axons? Proteomics Clin Appl (2007) 1.58
Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J Neurosci (2007) 1.58
Regulation of Rap2A by the ubiquitin ligase Nedd4-1 controls neurite development. Neuron (2010) 1.57
Global transcriptome analysis of genetically identified neurons in the adult cortex. J Neurosci (2006) 1.55
Sip1 regulates sequential fate decisions by feedback signaling from postmitotic neurons to progenitors. Nat Neurosci (2009) 1.54
Neuron to glia signaling triggers myelin membrane exocytosis from endosomal storage sites. J Cell Biol (2006) 1.49
A role for Schwann cell-derived neuregulin-1 in remyelination. Nat Neurosci (2012) 1.47
Beta1 integrins in radial glia but not in migrating neurons are essential for the formation of cell layers in the cerebral cortex. J Neurosci (2007) 1.45
Neuregulin-1, a key axonal signal that drives Schwann cell growth and differentiation. Glia (2008) 1.45
FAK is required for axonal sorting by Schwann cells. J Cell Biol (2007) 1.43
Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain (2007) 1.42
Cell depletion due to diphtheria toxin fragment A after Cre-mediated recombination. Mol Cell Biol (2004) 1.40
Arrest of myelination and reduced axon growth when Schwann cells lack mTOR. J Neurosci (2012) 1.39
Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice. Hum Mol Genet (2003) 1.32
Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models. J Lipid Res (2010) 1.31
Disturbed clockwork resetting in Sharp-1 and Sharp-2 single and double mutant mice. PLoS One (2008) 1.28
Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: implications for Pelizaeus-Merzbacher disease. J Cell Biol (2002) 1.27
Calcium activation of the LMO4 transcription complex and its role in the patterning of thalamocortical connections. J Neurosci (2006) 1.27
Quantitative and integrative proteome analysis of peripheral nerve myelin identifies novel myelin proteins and candidate neuropathy loci. J Neurosci (2011) 1.26
Evolution of a neuroprotective function of central nervous system myelin. J Cell Biol (2006) 1.25
Early ultrastructural defects of axons and axon-glia junctions in mice lacking expression of Cnp1. Glia (2009) 1.25
Deficiency of lipoprotein lipase in neurons modifies the regulation of energy balance and leads to obesity. Cell Metab (2011) 1.25
CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS. Glia (2005) 1.22
Cdc42 and Rac1 signaling are both required for and act synergistically in the correct formation of myelin sheaths in the CNS. J Neurosci (2006) 1.22
Hippocampal cGMP-dependent protein kinase I supports an age- and protein synthesis-dependent component of long-term potentiation but is not essential for spatial reference and contextual memory. J Neurosci (2003) 1.20
Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes. J Neurosci (2006) 1.20
A transcriptional network coordinately determines transmitter and peptidergic fate in the dorsal spinal cord. Dev Biol (2008) 1.19
Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy. Ann Neurol (2007) 1.18
Fibroblast growth factor receptor signaling in oligodendrocytes regulates myelin sheath thickness. J Neurosci (2012) 1.17
Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy. EMBO Mol Med (2012) 1.17
The role of myelin and oligodendrocytes in axonal energy metabolism. Curr Opin Neurobiol (2013) 1.17
Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Arch Gen Psychiatry (2010) 1.17
Beta1-integrin signaling mediates premyelinating oligodendrocyte survival but is not required for CNS myelination and remyelination. J Neurosci (2006) 1.16
NG2-expressing cells in the nervous system revealed by the NG2-EYFP-knockin mouse. Genesis (2008) 1.12
The role of CNS glia in preserving axon function. Curr Opin Neurobiol (2009) 1.12
Cholesterol regulates the endoplasmic reticulum exit of the major membrane protein P0 required for peripheral myelin compaction. J Neurosci (2009) 1.12
Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models. Neurogenetics (2009) 1.10
The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. BMC Psychiatry (2010) 1.10
Sox10-rtTA mouse line for tetracycline-inducible expression of transgenes in neural crest cells and oligodendrocytes. Genesis (2004) 1.09
Cre/loxP-mediated inactivation of the bHLH transcription factor gene NeuroD/BETA2. Genesis (2005) 1.08
SHARP1/DEC2 inhibits adipogenic differentiation by regulating the activity of C/EBP. EMBO Rep (2008) 1.08
Early neuronal and glial fate restriction of embryonic neural stem cells. J Neurosci (2008) 1.07
Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles. EMBO J (2013) 1.06
Perturbed interactions of mutant proteolipid protein/DM20 with cholesterol and lipid rafts in oligodendroglia: implications for dysmyelination in spastic paraplegia. J Neurosci (2006) 1.05
Phylogeny of proteolipid proteins: divergence, constraints, and the evolution of novel functions in myelination and neuroprotection. Neuron Glia Biol (2009) 1.04
Misalignment of PLP/DM20 transmembrane domains determines protein misfolding in Pelizaeus-Merzbacher disease. J Neurosci (2011) 1.04
Bace1 processing of NRG1 type III produces a myelin-inducing signal but is not essential for the stimulation of myelination. Glia (2011) 1.04
Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J Pineal Res (2006) 1.04
A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proc Natl Acad Sci U S A (2005) 1.03
Animal models of inherited neuropathies. Curr Opin Neurol (2006) 1.02
Evolution of myelin proteolipid proteins: gene duplication in teleosts and expression pattern divergence. Mol Cell Neurosci (2005) 1.01
Sialoadhesin deficiency ameliorates myelin degeneration and axonopathic changes in the CNS of PLP overexpressing mice. Neurobiol Dis (2006) 1.01
A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia. EMBO Mol Med (2011) 1.00
Subtle myelin defects in PLP-null mice. Glia (2006) 1.00
Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet. Nat Med (2012) 0.98
A critical role for the cholesterol-associated proteolipids PLP and M6B in myelination of the central nervous system. Glia (2013) 0.97
Phosphatidylinositol 4,5-bisphosphate-dependent interaction of myelin basic protein with the plasma membrane in oligodendroglial cells and its rapid perturbation by elevated calcium. J Neurosci (2009) 0.97
Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves. Mol Cell Neurosci (2002) 0.97
Neuron-glia signaling and the protection of axon function by Schwann cells. J Peripher Nerv Syst (2010) 0.97
Interaction of syntenin-1 and the NG2 proteoglycan in migratory oligodendrocyte precursor cells. J Biol Chem (2008) 0.96
Ablation of cholesterol biosynthesis in neural stem cells increases their VEGF expression and angiogenesis but causes neuron apoptosis. Proc Natl Acad Sci U S A (2009) 0.95
Oligodendroglial impact on axonal function and survival - a hypothesis. Curr Opin Neurol (2008) 0.94
The SNARE protein SNAP-29 interacts with the GTPase Rab3A: Implications for membrane trafficking in myelinating glia. J Neurosci Res (2009) 0.94
Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease. EMBO Mol Med (2010) 0.94
Palmitoylation is a sorting determinant for transport to the myelin membrane. J Cell Sci (2005) 0.94
Cholesterol: a novel regulatory role in myelin formation. Neuroscientist (2011) 0.93
A myelin gene causative of a catatonia-depression syndrome upon aging. EMBO Mol Med (2012) 0.92
PD-1 regulates neural damage in oligodendroglia-induced inflammation. PLoS One (2009) 0.92
Transport of the major myelin proteolipid protein is directed by VAMP3 and VAMP7. J Neurosci (2011) 0.92
Peroxisomal multifunctional protein-2 deficiency causes neuroinflammation and degeneration of Purkinje cells independent of very long chain fatty acid accumulation. Neurobiol Dis (2013) 0.91
PLP/DM20 expression and turnover in a transgenic mouse model of Pelizaeus-Merzbacher disease. Glia (2010) 0.90
Transgenic overexpression of the type I isoform of neuregulin 1 affects working memory and hippocampal oscillations but not long-term potentiation. Cereb Cortex (2011) 0.90
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet J Rare Dis (2014) 0.89
Adapting brain metabolism to myelination and long-range signal transduction. Glia (2014) 0.89
Role of CNPase in the oligodendrocytic extracellular 2',3'-cAMP-adenosine pathway. Glia (2013) 0.89
Survival of adult neurons lacking cholesterol synthesis in vivo. BMC Neurosci (2007) 0.88